Brenton Karl Ahrens, Director at Iterum Therapeutics plc (ITRM), sold 37,246 shares at $1.90 ($68K) on 2022-09-16, disclosed to the SEC on 2022-09-20.
Open-market sale of $68k ITRM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.90 | 15,000 | $29K | 41.9% |
| 2 | $1.77 | 15,000 | $27K | 39.1% |
| 3 | $1.78 | 7,246 | $13K | 19.0% |
| Total | $1.82 avg | 37,246 | $68K | 100% |
| Filing → |
| ITRM | BUY | 2018-05-30 | $6.6M | — | Filing → |
| DRTX | BUY | 2012-07-26 | $5.0M | — | Filing → |
| ACTV | SELL | 2012-03-06 | $3.1M | — | Filing → |